ilmscore | Prediction Details
"I do think shares of him and hers eventually rebounds on some of that news. But first, it's likely to see a sell-off on the crackdown to compounds... once him and hers finally stops selling these compounds or stops making these compounds available on his platform, that brings Novo Nordisk back in for this deal and the price jumps again. But I think you have to wait for that to happen."
By Let's Talk Money! with Joseph Hogue, CFA | August 19, 2025 | Pending
From video
Buy Heavy! This is How I Found the Next 158% Stock 00:12:30 - 00:13:33
Interpreted Prediction
Hims & Hers (HIM) stock is predicted to first experience a sell-off due to the crackdown on compounded drugs, then rebound with a price jump once it stops selling them and potentially renews its partnership with Novo Nordisk.

Prediction Details

Ticker
HIM

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.